Vamil K Divan
Vamil Divan, MD has worked in equity research at Credit Suisse since 2007 and is now the Senior Analyst covering the U.S. Pharmaceutical sector. From 2011-2013 he led the Life Science Tools and Diagnostics team and prior to that he was a member of the U.S. Pharmaceuticals team. Before joining Credit Suisse, Vamil worked in the pharmaceutical industry. He was an Associate Director at Roche in Drug Safety and Risk Management and then a Medical Director at Pfizer with a focus on commercial products in neuroscience and inflammation. Vamil holds an MD degree from the University of Buffalo, an MBA from New York University. He did his Internal Medicine residency at Mount Sinai Medical Center in New York City and then was a practicing physician prior to joining the pharmaceutical industry.